Oncology News | pharmaphorum

News

GSK scores major trial win with potential multiple myeloma b...

GlaxoSmithKline may have scored a major cancer trial win after its belantamab mafodotin hit targets in the pivotal DREAMM-2 trial in relapsed multiple myeloma.

News

AZ's immunotherapy combo misses the mark in untreated lung c...

AstraZeneca’s immunotherapy combination has missed the mark in certain patients with untreated lung cancer, failing to improve survival compared with standard chemotherapy in a phase 3 tria

News

Roche's CMO Horning to retire, Lilly's high-flyer Garraway s...

Roche’s influential chief medical officer Sandra Horning is to retire at the end of the year, the company has confirmed, to be replaced by a high-flyer from rival Eli Lilly.

News

Celgene scores regulatory win ahead of BMS merger

Celgene has scored a major regulatory win ahead of its proposed merger with Bristol-Myers Squibb, with the FDA backing its rare bone marrow cancer drug Inrebic.

News

FDA approves Roche's "tumour agnostic" drug Rozlytrek

The FDA has approved Roche’s Rozlytrek (entrectinib), a so-called “tumour agnostic” drug that is approved to key into certain mutations in cancer, instead of where the disease originates. <

News